Stem cells can actually be helpful in treatment of Diabetes

Must Read

COVID India Updates: MoHW urges to avoid mass gathering

New Delhi, March 6 (IANS) The Ministry of Health and Family Welfare has asked the states and union territories...

An Institute For Political Training Soon

ANI | In a first, An Institute For Political Training is coming soon in Ghaziabad. UP govt has approved setting...

Anna Burns win Man Booker Prize for ‘Milkman’

ANI | Northern Irish writer Anna Burns was announced the winner of the 50th Man Booker Prize for Fiction...
More than just being a girl next door, a homemaker and a mother, Richa is an aware human being too. She loves everything about this world, but never ready to compromise with the wrongs. Here she presents the world the way she views it. Richa, a Biotech Professional writes here about all the health-related topics and Lifestyle trends. Write to me at

It turns out that scientists who are striving to create more effective treatments for diabetes are turning towards stem cells.

- Advertisement -

Stem cells can be transformed into cells that produce insulin, the hormone that controls sugar.

However, the amount of insulin produced by these cells is difficult to control.

By tweaking the recipe for coaxing human stem cells into insulin-secreting beta cells, a team of researchers at Washington University School of Medicine in St. Louis has shown that the resulting cells are more responsive to fluctuating glucose levels in the blood.

The scientists found that when they transplanted the beta cells into mice that were unable to make insulin, the new cells began secreting insulin within a few days. They continued to control blood sugar in the animals for months.

The study was published in the journal Stem Cell Reports.

Speaking about the study, principal investigator Jeffrey R. Millman said, “We’ve been able to overcome a major weakness in the way these cells previously had been developed. The new insulin-producing cells react more quickly and appropriately when they encounter glucose.”

Millman, PhD, an assistant professor of medicine and of biomedical engineering added, “The cells behave much more like beta cells in people who don’t have diabetes.”
The researchers believe that it may be time to evaluate whether the same stem-cell approach could produce insulin and effectively control blood sugar in people.

Millman was earlier part of a research team at Harvard that, in 2014, converted skin cells into stem cells, and, in 2016, did the same thing with skin cells from a patient with diabetes. Each time, the stem cells were then treated with various growth factors to coax them into insulin-secreting beta cells. The beta cells, however, didn’t work as well as the researchers had hoped.

However, for the new study, Millman’s laboratory still grew beta cells from human stem cells, but they made numerous changes to the “recipe” for producing insulin-producing beta cells, treating the cells with different factors at different times as they grew and developed to help the cells mature and function more effectively.

Once complete, the researchers transplanted the beta cells into diabetic mice with suppressed immune systems so that they wouldn’t reject the human cells. Those transplanted cells produced insulin at levels that effectively controlled blood sugar in the mice, functionally curing their diabetes for several months, which, for most of the mice in the study, was about the length of their lives.

As laboratory researcher rather than a clinician, Millman said he can’t predict exactly when such cells may be ready for human trials but believes there are at least two ways that stem cell-derived beta cells could be tested in human patients.

The first, he says, would be to encapsulate the cells in something like a gel, with pores small enough to prevent immune cells from getting in but large enough to allow insulin to get out. He added, “Another idea would be to use gene-editing tools to alter the genes of beta cells in ways that would allow them to ‘hide’ from the immune system after implantation.”

According to Millman, if stem cell-derived beta cells are proven safe and effective for people with diabetes, his method of manufacturing the cells could be increased up to an industrial scale.


(Souce: ANI)


Please enter your comment!
Please enter your name here

Latest News

We succeeded in saving country from stage 3: Health Minister

New Delhi, April 25 (IANS) Union Health Minister Harsh Vardhan on Friday said we have saved India from going...

Dietary supplements important weapon for fighting off COVID-19

New York, April 25 (IANS) Supplements containing vitamins C and D and other micronutrients are a safe, effective and low-cost means of helping your...

Instagram launches in-app food delivery to support businesses

San Francisco, April 25 (IANS) Facebook-owned photo and video-sharing app Instagram has launched a new feature that allows food orders to be placed through...

India has so far gifted $5 million medical supplies to world to combat Covid-19

New Delhi, April 24 (IANS) India has gifted USD 5 million worth of medicines and other Covid-19 related supplies to the world so far...

India needs to incentivise charger manufacturing: Top industry body

New Delhi, April 24 (IANS) Smartphone chargers and Printed Circuit Board Assembly (PCBA) are two mobile components that could help India achieve its manufacturing...

No exponential rise in Covid-19 cases in country: Health Ministry

New Delhi, April 23 (IANS) The Centre said on Thursday that the rise in coronavirus cases in the country has been more or less...

Google will now verify all of its advertisers on its platforms

San Francisco, April 23 (IANS) To provide greater transparency and equip users with more information about who is advertising to them, Google on Thursday...

HP to provide free resources to students, educators in India

New Delhi, April 23 (IANS) PC and printer major HP Inc. on Wednesday announced its partnership with educational content provider Gamooz in India to...

Can Facebook become Amazon of the world with Reliance Jio?

New Delhi, April 23 (IANS) Mark Zuckerberg-run Facebook has interestingly chosen India to begin its global ecommerce journey with investing $5.7 billion (approx. Rs...

More Articles Like This